Getting used to Claude as a pretend Regent? Your truly asked Claude to review items F6 and F7 from the agenda today, summarize, and ask questions. Both are UCLA items. Below is the response:
Regent's Risk Review: UCLA Capital Items F6 and F7
Finance and Capital Strategies Committee, Meeting of November 18, 2026
Prepared from the Office of the President action items. This is a cautious review written from a regent's point of view.
Bottom line
Each item has a sound purpose. The risks are different:
- F6 (Research Park East) asks us to approve $137 million of new UCLA debt while the campus fails two of the three tests in the University's Debt Policy. The CFO has granted an exception. Most of the construction would also be run by an outside nonprofit under an agreement that is still being negotiated.
- F7 (West Valley Hospital) asks for $120 million just for preliminary plans on a project whose total cost is not disclosed. That project will very likely cost more than $1 billion. It also follows an acquisition whose original retrofit plan has now been abandoned, and it will miss the state's 2030 seismic deadline.
I would not oppose either item outright. I would want the questions below answered on the record before voting, and I would consider asking for conditions on F6.
Item F6: UCLA Research Park East Core and Shell Improvements (Budget and External Financing)
What is being proposed
- Retrofit about 530,000 gsf of the 736,000-gsf east building of UCLA Research Park for multi-tenant scientific use, mainly biomedical and quantum physics labs. Initial occupants: the California Institute for Immunology and Immunotherapy (CIII), the Geffen School of Medicine, and the UCLA Quantum Innovation Hub.
- The work covers new mechanical, electrical and plumbing systems, converting rooftop parking to a central plant, floodproofing and floodplain mitigation, and new entries and lobbies. Lab tenant improvements are not included. They will come back as separate projects, starting with preliminary plans in March 2027.
- Total budget: $327.9 million. In September 2026 the Regents approved $54 million for preliminary plans, working drawings and Advanced Work Phase construction.
- Funding sources:
- Campus funds: $44.9M (13.7%)
- External financing repaid from campus general revenues: $92.2M (28.1%)
- External financing repaid from gifts: $44.8M (13.7%)
- CIII funds: $145.9M (44.5%)
- Debt service, at a 4.25% planning rate over 30 years (2029–2058): about $5.49M a year on the $92.2M and $2.67M a year on the gift-supported $44.8M. That totals about $8.2M a year.
- Delivery: Under the 2024 Master Lease and Affiliation agreement, CIII would lead construction using a Construction Manager at Risk (CMAR), and the same CMAR would build CIII's tenant improvements. The Work Agreement with CIII is still being negotiated.
- Schedule: Advanced Work runs Oct 2026 – Jan 2027. Full construction runs Dec 2026 – May 2029.
Key risk flags
- The campus fails the Debt Policy. The minimum modified cash flow margin is -0.4% against a required ≥0.0%. Debt service coverage is 0.5x against a required ≥1.1x, a threshold the attachment marks "Must Meet." Only days cash on hand passes (102 days against ≥90), and only narrowly. A coverage ratio of 0.5x means projected cash flow covers about half of debt service. The CFO granted an exception. The Regents should understand that we are being asked to approve debt the University's own policy would normally reject.
- The gift-backed debt is really campus debt. The $44.8M is repaid "from gift funding," but the pledged security is the same as for the other loan: general revenues of the Los Angeles campus. If pledges are not collected on time, the campus pays. The item doesn't say how much of the $44.8M is already pledged, collected or under signed agreements.
- An outside party controls construction. An independent nonprofit (CIII) would run the CMAR contract for a UC-owned building in which UC has about $182M at stake. The Work Agreement is not finished. Allocation of overruns, change-order authority, audit rights and UC oversight are not described.
- Counterparty dependence. CIII provides 44.5% of funding. If CIII's funding is delayed, reduced or redirected, or its program changes, UCLA could be left funding the gap or holding unleased lab-ready space.
- Retrofit cost risk with no benchmarks. The item says "adequate comparable projects are not available." Building cost is $472/gsf and total P-W-C cost is $609/gsf. Contingency is $28.5M (8.8%), which is thin for a deep retrofit of an existing building with floodplain issues, a rooftop-to-plant conversion and full MEP replacement.
- This is only the first installment. The core and shell does not create usable labs. UCLA tenant improvements, the remaining eastern portion and all of Research Park West are later phases "as additional tenants are identified and funding is secured." Our total commitment to make this facility productive is not shown.
- No revenue case is shown. The item gives no lease income from CIII, sublease or industry revenue, indirect cost recovery or operating cost projections. Repayment relies entirely on campus general revenues.
- Research funding environment. The campus already fails coverage tests. Its general revenues depend partly on federal research funding, which has been volatile, and the item does not discuss this sensitivity.
- Reimbursement and timing. The financing may reimburse prior spending, and the revised sources table shows external financing and gift funds in phases previously approved as campus and CIII funds. Advanced Work construction began in October, before this financing approval.
Questions I would want answered
Debt affordability
- What specific conditions led the CFO to grant the Debt Policy exception, and what is the campus plan and timeline for getting back to ≥0.0% margin and ≥1.1x coverage?
- The benchmark table lists the minimum metrics in "2025." Which projection year is the low point, and what do the ten-year margin and coverage trajectories look like year by year?
- What other UCLA campus financings are planned in the same ten-year window, and are they in the Debt Affordability Model that produced these numbers?
- What are coverage and cash-on-hand under a downside scenario: a 10–20% drop in federal research funding, lower state support, or rates of 5.5–6%?
- If the exception is granted, what reporting will the Regents receive, and are there triggers that would pause future UCLA borrowing?
Gift funding
- How much of the $44.82M is in signed pledges, how much is received, and how much is still prospective? What is the pledge payment schedule against the $2.67M annual debt service?
- If gifts fall short, does the shortfall fall entirely on campus general revenues? Has that downside been modeled in the coverage ratio?
CIII relationship and delivery
- What is the source of CIII's $145.9M? Is it fully committed and on hand, or subject to appropriation, fundraising or milestones?
- Under the draft Work Agreement, who bears cost overruns on the core and shell? Is the "pro-rata share" fixed, or does UCLA absorb increases?
- What approval rights, audit rights and change-order controls will UC have over a CIII-managed CMAR contract? Who holds the guaranteed maximum price?
- Why should the Regents approve the full budget and financing before the Work Agreement is executed? Should approval be conditioned on execution of an agreement meeting specified terms?
- Using one CMAR for both UC core and shell and CIII tenant improvements is said to save time and money. How will costs be kept separate so UC does not subsidize CIII's tenant work?
- What happens to UCLA's investment if CIII defaults on its lease or affiliation obligations, or dissolves?
Scope, cost and economics
- Without comparables, what independent cost estimate or peer review validated the $327.9M budget? Is 8.8% contingency adequate for a building of this age and condition, including flood mitigation?
- What is the estimated total cost, including UCLA tenant improvements, to make UCLA's share of Research Park East fully operational, and how will it be funded?
- What rent will CIII and other tenants pay, and what are projected operating and maintenance costs? Does the project produce net income for the campus or a net cost?
- How much of the 530,000 gsf is committed to identified tenants, and how much is speculative?
- What is the remaining flood risk after mitigation, and what are the insurance implications for lab space in a floodplain?
Item F7: UCLA West Valley Medical Center Replacement Hospital and Parking Structure (Preliminary Plans Funding)
What is being proposed
- Build a replacement acute care hospital of about 585,000 gsf on the East Campus of the former West Hills Hospital, acquired in March 2024. The existing 188,000-gsf hospital was built in 1973, does not meet SB 1953 seismic standards, and UCLA Health now says a retrofit is not financially or operationally feasible.
- Tentative program: 260–300 licensed beds, an emergency department, interventional services, advanced radiology, a burn unit, clinical support and an all-electric central utility plant. Also included: a 650-space parking structure built first, demolition of old buildings, and limited improvements to the existing ED/ICU building, whose new use is undefined.
- Request: $120 million for preliminary plans, from hospital reserves. Of that, $87.5M (72.9%) is architecture and engineering fees and $25.7M (21.4%) is special items.
- The total project budget is not disclosed. UCLA Health will return in spring 2028 (parking structure) and fall 2028 (hospital) for full budgets, external financing and design approval. Environmental review under CEQA has not yet been done.
- Schedule: about nine years. Hospital completion is expected in 2034 and the full project in 2036. UCLA Health told the state agency (HCAI) the project will not meet the 2030 seismic deadline.
- Hospital system financials (as of June 30, 2025): 15.5% modified net margin, 8.7x modified debt service coverage, 219 days cash. Ten-year projections meet Debt Policy.
Key risk flags
- Very large commitment with no total cost. $120M of preliminary planning is a large sum on its own. It strongly implies a total project well above $1 billion, but no estimate is given. Once $120M is spent, pressure to approve the full project in 2028 will be considerable.
- Acquisition due-diligence questions. When UCLA bought the hospital, it expected to renovate and retrofit it into compliance. Two and a half years later, that plan is deemed infeasible and a full replacement is proposed. The Regents should understand what changed and whether the purchase price and business case anticipated this.
- Seismic and regulatory exposure. The project will miss the 2030 SB 1953 deadline by about four years. The item says HCAI will stop approving any modifications to the existing facility without an acceptable plan. It does not say what penalties, licensing actions or operating restrictions could follow if HCAI does not grant an extension. Patients would also stay in a non-compliant 1973 building through 2034.
- Limited capacity gain. Beds go from 260 licensed to 260–300, while building area roughly triples (188,000 to 585,000 gsf). The growth case depends more on new service lines (burn unit, interventional, tertiary care) than on beds.
- Financial data are dated and the outlook is uncertain. Hospital metrics are as of June 30, 2025, more than 16 months old. Hospital finances face potential pressure from federal Medicaid changes, payer mix shifts, labor costs and construction cost inflation. The projected coverage range of 3.4x–9.8x is wide.
- Reserves are being drawn for multiple purposes. UCLA Health has major capital needs and recent acquisitions. The item doesn't show the cumulative draw on reserves or how this project ranks against other commitments.
- Scope is still undefined. The bed count, square footage, ED/ICU reuse and service mix will be "refined." The PDB method sets a guaranteed maximum price only after award and design. That brings early contractor input but less early cost certainty.
- Operational and site risks. The existing hospital must keep operating during roughly nine years of construction. The new parking structure (650 spaces) replaces part of today's 1,070 surface spaces. An all-electric central plant for an acute care hospital raises questions about resilience and backup power.
Questions I would want answered
Total cost and financing
- What is UCLA Health's current estimated range for total project cost, including the parking structure, demolition and ED/ICU work? What will the financing mix be (debt versus reserves versus philanthropy)?
- Why is $120M (with $87.5M in A&E fees) the right size for preliminary plans? What share of total cost does it represent, and how does it compare with other recent UC hospital replacement projects?
- If the full project is later scaled back, delayed or rejected, how much of the $120M would still be useful (for example for a retrofit or a smaller alternative)?
- Can the $120M be released in tranches tied to milestones, such as a cost estimate after programming, before all of it is committed?
Acquisition history and alternatives
- What was the purchase price for the East and West Campus properties? What retrofit cost was assumed at acquisition, and what did the later assessment find?
- What alternatives were evaluated: a phased retrofit, a smaller replacement, building on the West Campus parcels, or partnering with another provider? Please provide the comparative costs.
- What lessons from this acquisition apply to future UC health system acquisitions and their due diligence?
Seismic compliance and regulation
- Has HCAI formally accepted the plan or granted an extension beyond 2030? If not, what are the possible consequences, including fines, license restrictions or forced closure of inpatient services?
- What interim measures will protect patients and staff in the 1973 building until 2034?
- Which schedule milestones are critical to keep HCAI's cooperation, and what happens if the 2028 approvals slip?
Business case and finances
- Please provide updated hospital system financials for FY 2025-26 and a downside scenario reflecting federal Medicaid and payer changes.
- What volume, market share and payer-mix assumptions support a 585,000-gsf facility? What is the expected return on investment?
- What are all of UCLA Health's capital commitments over the next ten years, and how much reserve capacity remains after this project?
- What drives the new burn unit and tertiary services: demonstrated regional demand, or strategic positioning? What would they cost to staff?
Delivery and operations
- How will cost overruns be controlled before a guaranteed maximum price is set under PDB? What cost reports will the Regents receive?
- Is 650 structured spaces enough once the new hospital and repurposed ED/ICU are fully operating? Will additional parking or traffic mitigation be needed?
- How will an all-electric central plant meet hospital requirements for continuous operation during grid outages or a major earthquake?
- What is the plan and budget for the repurposed ED/ICU building, and could it add material cost later?
Cross-cutting concern
Both items fall on UCLA's balance sheet at the same meeting. They show a sharp contrast: the health system reports strong margins and coverage, while the campus side fails the Debt Policy. I would ask the CFO for a combined view of UCLA's ten-year borrowing and reserve use across campus and health. I would also ask whether a series of Debt Policy exceptions for the campus is becoming the norm rather than the exception.
Possible conditions to consider (F6)
- Make the financing approval effective only after a CIII Work Agreement is executed with UC cost-overrun protection, audit rights and approval rights over changes.
- Require documentation of committed CIII funds and gift pledges before drawing on the gift-supported financing.
- Require an annual report to the Committee on campus debt metrics until they return to compliance.
Arithmetic note: funding sources total $327.864M, and the stated debt service figures check out at 4.25% over 30 years. The over-$1-billion figure for F7 is my own rough inference from the size of the planning budget and the building; it is not a number in the agenda item.




